Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples